Press Releases

OncoSec Announces Closing of First Tranche of $15 Million At Market Investment from Alpha Holdings, Inc.

Oct 09, 2018 8:00am EDT

OncoSec Chief Scientific Officer to Present at Advances in Immuno-Oncology USA Congress

Oct 08, 2018 8:00am EDT

Data from OncoSec's OMS-100 Clinical Trial Accepted for Oral Presentation at the 2018 Melanoma Bridge Conference

Oct 02, 2018 8:00am EDT

OncoSec to Present at Cantor Fitzgerald Global Healthcare Conference

Sep 25, 2018 7:30am EDT

OncoSec Announces $15 Million At Market Investment from Alpha Holdings, Inc.

Sep 04, 2018 7:30am EDT

OncoSec to Present at H.C. Wainwright 20th Annual Global Investment Conference

Aug 31, 2018 8:00am EDT

OncoSec Appoints Alain Algazi, MD, as Clinical Strategic Advisor

Aug 28, 2018 8:00am EDT

OncoSec Enters Research Collaboration Agreement with UCLA and Roger S. Lo, M.D., Ph.D.

Aug 06, 2018 8:00am EDT

OncoSec Appoints Robert W. Ashworth, Ph.D. as Vice President, Regulatory

Jul 30, 2018 8:00am EDT

OncoSec Presents Update from Triple Negative Breast Cancer Program at 3rd Global Insight Conference on Breast Cancer

Jul 17, 2018 8:00am EDT